The median overall survival for the experimental arm was 193 v 182 days for the control arm ( P = .75 ) ; 6-month and 1-year survival rates were 53 % and 27 % v 49 % and 24 % for the control arm , respectively ; median progression-free survival was 112 v 109 days for the control arm .
